Skip to main content
SpringerLink
Log in

Arterielle Hypertonie

  • Chapter
Klinische Kardiologie

  • 134 Accesses

Zusammenfassung

In Abhängigkeit von der Erhöhung des systolischen und/oder des diastolischen Blutdrucks unterscheidet man verschiedene Formen der Hypertonie (s. Tabelle 38-1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Joint National Committee on Detection, E., and Treatment of High Blood Pressure (1997) The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 157: 2413–2446

    Google Scholar 

  2. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liasison Committee (1993) Guidelines for the management of mild hyperension. Hypertension 22: 392–403

    Article  Google Scholar 

  3. Veterans-Administration Cooperative Study Group on Antihypertensive Agents (1976) Effects of treatment and morbidity in hypertension. JAMA 202: 1028–1036

    Google Scholar 

  4. SHLP-Cooperative-Research-Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHED).lAMA 265: 3255–3264

    Google Scholar 

  5. Schmidt MI et al. (1996) Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis risk in Communities Study Investigators. Metabolism 45: 699 706

    Google Scholar 

  6. Ilouston,VI(: (1991) flypertcnsion strategies for therapeutic intervention and prevention of end-organ damage. Prim Care Clin North Mn 18: 713 753

    Google Scholar 

  7. Baba T, Ncugehaucr S (1994) ‘pm link between insulin resistance and hypertension.11iterts of antihypertensive and antihyperlipidaemicdrugs on insulin sensitivity. Drugs 47: 383-4o4

    Google Scholar 

  8. Shepherd JT (1990) Increased systemic vascular resistance in primary hypertension: the expanding cumplexity. J I lypertens 8 (Suppl 7): S t5 s 19

    Google Scholar 

  9. Joint National (,ununiltec on Detection, L., and Treatment of li pli I luod Press iru (n99;) The filth report of the Joint National(,nnunilteeun Doe) hum, h.valualion,and1reatinenlof Iligh ttluod t’ressllrcONC.V).Arch Intern Med 15i: 154 18;

    Google Scholar 

  10. Laragh JH, Brenffner BM (199o) Hypertension. Pathophysiology, diagnosis and management, vols I & II. Raven, New York

    Google Scholar 

  11. Swales JT (ed) (1994) Textbook of hypertension. Blackwell, London, p 1328

    Google Scholar 

  12. Kurtz TW, Spence MA (1993) Genetics of essential hypertension. Am J Med 94: 77–84

    Google Scholar 

  13. Williams RR et al. (199o) Multigenic human hypertension: evidence for subtypes and hope for haplo-types. J Hypertens 8: S 39-S 45

    Google Scholar 

  14. Caulfield M et al. (1994) Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330: 1629–1633

    Article  PubMed  CAS  Google Scholar 

  15. Lindpaintner K (1994) Genes, hypertension, and cardiac hypertrophy. N Engl J Med 330: 1678–1679

    Article  PubMed  CAS  Google Scholar 

  16. Kurokawa K, Okuda T (1998) Genetic and non-genetic basis of essential hypertension: maladaptation of human civilization to high salt intake. Hypertens Res 21: 67–71

    Article  PubMed  CAS  Google Scholar 

  17. Laakso M, I:ehto S (1998) Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 137 (Suppl): S 65-S 73

    Google Scholar 

  18. Whelton PK, He J, Klag MJ (1994) Blood pressure in westernized populations. In: Swales JD (ed) Textbook of hypertension. Blackwell, London, p 11–21

    Google Scholar 

  19. Gorey KM, Trevisan M (1998) Secular trends in the United States black/white hypertension prevalence ratio: potential impact of diminishing response rate. Am J Epidemiol 47: 95–102

    Article  Google Scholar 

  20. Magrini F, Reggiani P (1992) Epidemiology of hypertension in Europe. bur I heart J 13 (Suppl li): 27–34

    Google Scholar 

  21. Vokonas PS, Kannel WB, Cupples LA (1988) Epidemiology and risk of hypertension in the elderly: the Framingham Study. J I lypertens 6 (Suppl 1): S 3 S 9

    Google Scholar 

  22. Ferrannini E, Natali A (1991) The insulin resistance syndrome. Cardiovasc Risk I’m.- 1 /6: 386–392

    Google Scholar 

  23. Ferrannini F. et al. (1991) llyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome Diabetologia134:.110.t2_

    Google Scholar 

  24. Salvetti A et al. (1993) What effect dies blood pressure control 54• have on the progression toward renal disease. Am J Kidney Dis 21 (Stipp’ 3): 10–15 55.

    Google Scholar 

  25. Fournier AM, Hoenig LJ, Sosenko JM (1993) The degree of blood pressure evaluation and end organ damageevere hypertension: A case-control study. Am J Med Sci 306: 367–370

    Google Scholar 

  26. Sideris DA (1993) High blood pressure and ventricular arrhyth- 56. mias. Eur Heart J 14: 1548–1553

    Article  PubMed  CAS  Google Scholar 

  27. Kay LE (1998) Accuracy of blood pressure measurement in the family practice center. J Am Board Fam Pract n: 252–258

    Google Scholar 

  28. Vetter H, Vetter W (1986) Praktische Hypertonie. Thieme, Stuttgart, S 119

    Google Scholar 

  29. Netea RT et al. (1998) Does it matter whether blood pressure measurements are taken with subjects sitting or supine? J Hypertens 16: 263–268

    Article  PubMed  CAS  Google Scholar 

  30. Akpunonu B, Mulrow P, Hoffman E (1996) Secondary hypertension: evaluation and treatment. Disease-A-Month Oct 96: 613–722

    Google Scholar 

  31. Wylie EJ, Perloff JS, Wellington JS (1962) Fibromuscuflar hyperplasia of the renal arteries. Ann Surg 156: 952–958

    Google Scholar 

  32. Krijnen P et al. (1998) A clinical prediction rule for renal artery stenosis. Ann Intern Med 129: 705–711

    Article  PubMed  CAS  Google Scholar 

  33. Hany S et al. (1987) Circadian blood pressure variability in secondary and essential hypertension. J Hypertension 5 (Suppl 5): S 487-S 489

    Google Scholar 

  34. Tello R et al. (1998) Detection of renal arteries with fast spin-echo magnetic resonance imaging. Australas Radiol 42: 179–182

    Article  PubMed  CAS  Google Scholar 

  35. Olbricht CJ, Arlart IP (1998) Magnetic resonance angiography–the procedure of choice to diagnose renal artery stenosis? Nephrol Dial Transplant 13: 1620–1622

    Article  PubMed  CAS  Google Scholar 

  36. Hany TF et al. (1997) Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 204: 357–362

    Google Scholar 

  37. Arsenault TM et al. (1996) Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience. Mayo Clin Proc 71: 1150–1154

    Article  PubMed  CAS  Google Scholar 

  38. Tello R et al. (1998) Standard dose Gd-DTPA dynamic MR of renal arteries. J Magn Reson Imag 8: 421–426

    Article  CAS  Google Scholar 

  39. Mann SJ, Pickering TG (1992) Detection of renovscular hypertension: State of the art 1992. Ann Intern Med 117: 845–853

    Google Scholar 

  40. Textor SC (1994) Renovascular hypertension. Endocrin Meta-hol Clin North Am 23: 235-253

    Google Scholar 

  41. Tuttle KR et al. (1998) Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stellt. Am J Kidney Dis 32: 611–622

    Article  PubMed  CAS  Google Scholar 

  42. Sierre SD et al. (1998) ‘l’reatment of recurrent transplant renal artery stenosis with metallic stents. J Vase Intery Radiol 9: 639-644

    Google Scholar 

  43. Fiala LA et al. (1998) Primary stenting of atherosclerotic renal artery ostial stenosis. Ann Vasc Surg 12: 128–133

    Article  PubMed  CAS  Google Scholar 

  44. Stanley JC (1997) Surgical treatment of renovascular hypertension. Ans J Surg 174: 102–110

    Article  CAS  Google Scholar 

  45. Cook DM (1997) Adrenal mass. Endocrinol Metahol Clin North Am 26: 829–852

    Article  CAS  Google Scholar 

  46. Gartner F, Grotz W, Schollmeyer P (1998) Differenzierte Diagnostik and Therapie des primären Hyperaldosteronismus. Dtsch Med Wochenschr 123: 873–876

    Article  PubMed  CAS  Google Scholar 

  47. Gomez-Sanchez CE (1998) Primary aldosteronism and its variants. Cardiovasc Res 37: 8–3

    Google Scholar 

  48. Bravo EL (1994) Primary Hyperaldosteronisns. Issues in diagnosis and management. Endocrinol Metabol Clinics North Am 23: 271–283

    CAS  Google Scholar 

  49. Bravo EL, Tarazi RC, Dustan HP (1983) The changing clinical sepctrunt of primary aldosteronism. Am I Med 74: 641–648

    Article  CAS  Google Scholar 

  50. Dluhy RE, Litton RP (1994) Glucocorticoid-remediable aldosteronism. Endocrinol Metabol Clin North Am 23: 285–297

    CAS  Google Scholar 

  51. Gifford RW, Manger WM, Bravo EL (1994)Pheochromozytonta. Endocrinol Metahol Clin North Ant 23: 387–405

    Google Scholar 

  52. Xian XR et al. (1998) Diagnosis and treatment of adrenal tumours: a review of 35 years experience. Br I UroI 82: 199–205

    Google Scholar 

  53. Bravo EL (1994) Evolving concepts in the pathophysiology, diagnosis, and treatment of phcochrontoivtonta. Endocrine Rev 15: 356–368

    CAS  Google Scholar 

  54. Troncone L, Rufini V (1997) 131-I MIBG therapy of neural crest tumours (Review). Anticancer Res 17/3E: 1823–1831

    Google Scholar 

  55. Loh KC et al. (1997) The treatment of malignant pheochromozytoma with iodine-131-metaiodobenzylguanidine (1311-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 20: 648–658

    PubMed  CAS  Google Scholar 

  56. Kaplan NM (1998) Clinical hypertension. Williams & Wilkins, Baltimore, pp 1–444

    Google Scholar 

  57. Vetter W, Feltkamp H (1991) Ambulante kontinuierliche Blutdruckselbstmessung (ABPM) vs. Blutdruckselbstmessung. Z Kardiol 80 (Suppl 1): 49–51

    Google Scholar 

  58. Taylor RS et al. (1998) Ambulatory blood pressure monitoring for hypertension in general practice. J R Soc Med 91: 301–304

    PubMed  CAS  Google Scholar 

  59. Tochikubo O et al. (1998) Statistical hase value of 24-hour blood pressure distribution in patients with essential hypertension. Hypertension 32: 430–436

    Google Scholar 

  60. Musso NR et al. (1997) Ambulatory blood pressure monitoring: how reproducible is it? Am J Hypertens l0: 936–939

    Article  CAS  Google Scholar 

  61. World Hypertension League (1988) Self-measurement of blood pressure. J Hypertens 6: 257–261

    Article  Google Scholar 

  62. Merrick RD et al. (1997) Factors influencing the accuracy of horn blood pressure measurement. South Med J 90: 1110–1114

    Article  PubMed  CAS  Google Scholar 

  63. Netea RT et al. (1998) Influence of the arm position on intra-arterial blood pressure measurement. J Hum Hypertens 12: 157–160

    Article  PubMed  CAS  Google Scholar 

  64. de-Gaudemaris R et al. (1996) Comparison of home and clinical blood pressue measurements: clinical applications. Z Kardiol 85 (Suppl 3): 60–65

    PubMed  Google Scholar 

  65. Ohkubo T et al. (1998) Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation onOhasama, Japan. J Hypertens 16: 971–975

    Article  PubMed  CAS  Google Scholar 

  66. Hsueh WA, Buchanan TA (1994) Obesity and hypertension. Endocrin Metahol Clin North Am 23: 405–427

    Google Scholar 

  67. Arakawa K (1993) Antihypertensive mechanism of exercise. J Hypertens u: 223–229

    Google Scholar 

  68. Levine GN, Balady GI (1993) The benefits and risks of exercise training: the exercise prescription. Ads, Int Med 38: 57–79

    CAS  Google Scholar 

  69. Shephard RJ, Astrand PO (1993) Ausdauer im Sport. Eine Veröffentlichung des IOC in Zusammenarbeit mit der FIMS. Dtsch Ärzte-Verlag, Köln

    Google Scholar 

  70. Shephard RJ (1994) Aerobic fitness and health. Champaign/111.: Human Kinetics 358

    Google Scholar 

  71. INTERSAIJ Cooperative Research Group (1988) INTERSALT: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Br Med J. 297: 319–328

    Article  Google Scholar 

  72. Muntzel M, Drüeke T (1992) A comprehensive review of the salt and blood pressure relationship. Ant J Hypertens 5:1 S-42 S

    Google Scholar 

  73. Luft FC, Weinberger MIL, Grins CE (1982) Sodium sensitivity and resistance in normotensive humans. Ans 1 Med 72: 720–735

    Google Scholar 

  74. Freeman ZS (1990) Streß and hypertension–a critical review. Med 1 Aust 153: 621–625

    CAS  Google Scholar 

  75. Goldberger L, Breznitz S (1993) Handbook of stress. Theoreti-cal and clincal aspects. Free Press, New York, pp 1–519

    Google Scholar 

  76. Suter PM, Vetter W (1993) Kaftee and Koffein. Einige ausgewahlte Aspekte fir den Praxisalltag. Schweiz Rundschau Med (PRAXIS) 82: 1122–1128

    Google Scholar 

  77. Brater DC (1998) Diuretic therapy. N Engl I Aled 339: 387–395

    CAS  Google Scholar 

  78. Shinton RA, Beavers DG (1990) A meta-analysis of mortality and coronary prevention in hypertensive patients treated with 3-receptor blockers. J Hunt Hypertens 8 (Suppl 2): 31–36

    Google Scholar 

  79. Cruikshank ISl, Prichard BN(..: (1988) Beta-blockers in clinical practice. Churchill-Livingstone, Edinburgh, p 388

    Google Scholar 

  80. Nlesserli PH, Grossman E, Goldbourt U (1998) Are beta-blokkers efficacious as tirst-line therapy for hypertension in the eldcly? A systematic review. JAMA 2,79: 1903–1907

    Google Scholar 

  81. Aronow WS (1997) “treatment of congestive heart failure in older persons. I Ant Genatr Soc 45: 1252–1257

    Google Scholar 

  82. Constant I (1998) A review of why and how we tua: use betablockers in congestive heart failure. Chest 113: 800–808

    Article  PubMed  CAS  Google Scholar 

  83. van-Nueten IM et al. (19981 Nehivolol vs. niiedipine in the treatment of essential hypertension: A double-blind, randomized, contparativc trial. Ant I ‘flier 5: 237–243

    Google Scholar 

  84. van-Nueten L, Taylor FR,Robertson JIS (1998) Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial. J Hum Hypertens 12: 135–140

    CAS  Google Scholar 

  85. Psaty BM et al. (1995) The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 274: 620–625

    Google Scholar 

  86. Furberg CD, Psaty BM, Meyer JV (1995) Nifedipine. Dose related increase in mortality in patients with coronary artery disease. Circulation 92: 1326–1331

    Google Scholar 

  87. Pahor M et al. (1995) Longterm survval and use of antihypertensive medications in older persons. J Am Geriatr Soc 43: 1191–1197

    PubMed  CAS  Google Scholar 

  88. Held P, Yusuf S, Furberg CD (1989) Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BY Med J 299: 1187–1192

    Article  CAS  Google Scholar 

  89. Opie LH (1997)Mechanisms whereby calcium channal antagonists may protect patients with coronary artery disease. Eur Heart J 18 (Suppl A): A92–1o4

    Google Scholar 

  90. Pepine CJ, Faich G, Makuch R (1998) Verapamil use in patients with cardiovascular disease: Am overview of randomized trials. Clin Cardiol 21: 633–641

    Google Scholar 

  91. Messerli FH,Grossman E (1998) The calcium antagonist controversy: A posthumous commentary. Am J Cardiol 82: 35R–39R

    Google Scholar 

  92. Alderman MH et al. (1997) Effect of long-acting and short acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 349. 594–598

    Article  PubMed  CAS  Google Scholar 

  93. Rangoonwala B, Schulz W, Bauer B (1996) Fixed dose combinations of ACE inhibitors. Br J Clin Pract 50: 454–465

    Google Scholar 

  94. GrobeckerH(1998)Angiotensin-Il-Rezeptorantagonisten.Wiss. Verlagsges., Stuttgart, S 1–126

    Google Scholar 

  95. Goodfriend TL, Elliott ME, Catt KJ (1996) Angiotensin receptors and their antagonists. N Engl J Med 334: 1649-i654

    Google Scholar 

  96. Kang PM et al. (1994) Angiotensin II receptor antagonists: A new approach to blockade of the renin-angiotensin system. Am Heart J 127: 1388–1401

    Google Scholar 

  97. Csikos T, Chung O, Unger T (1998) Receptors and their classification: focus on angiotensin II and the AT, receptor. J Hum Hypertens 12: 311–318

    Article  PubMed  CAS  Google Scholar 

  98. Wber MA (1997) Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension. J Hypertens (Suppl) 15: S 31–36

    Article  Google Scholar 

  99. Rush JE, Rajfer SI (1993) Theoretical basis for the use of angiotensin II antagonists in the treatment of heart failure. J Hypertens n (Suppl 3): 5 69–5 71

    Google Scholar 

  100. Pitt B et al. (1997) Randomised trial of losartan vs. captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349: 747–752

    Article  PubMed  CAS  Google Scholar 

  101. Angeli P et al. (1991) Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Arch Intern Med 151: 678–682

    Article  PubMed  CAS  Google Scholar 

  102. Dluhy RG (1998) Unvommon forms of secondary hypertension in older patients. Am J Hypertens 11: 52 S-56 S

    Google Scholar 

  103. Amery A et al. (1985) Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet I: 1349–1359

    Google Scholar 

  104. Dahlöf B et al. (1992) Further analyses of STOP-Hypertension–focus on secondary endpoints, side-effects and possible sex differences. J Hypertens 20 (Suppl 4): S 121–122

    Google Scholar 

Download references

Authors
  1. P. M. Suter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Vetter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik III, Universität zu Köln, Joseph-Stelzmann-Straße 9, 50924, Köln, Deutschland

    Erland Erdmann

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Suter, P.M., Vetter, W. (2000). Arterielle Hypertonie. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12156-6_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12156-6_38

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-12157-3

  • Online ISBN: 978-3-662-12156-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation